Story thread · 2 reports / 2 sources
Expedition gets another $115M for its twist on China NewCo model
endpts.com · 6d
A US biotech with a slightly different approach to the burgeoning NewCo model has raised another $115 million for its China-sourced COPD drug candidate. Virtual biotech Expedition Therapeutics disclosed the Series B Wednesday morning in ...
First report: A COPD drug from China draws $115M in venture funding — biopharmadive.com, 6d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.